We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AWKNF market cap is 3.09M. The company's latest EPS is CAD -0.1291 and P/E is -0.62.
| Year End January 30 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 246k | 1.5M | 1.05M |
| Operating Income | -9.78M | -9.19M | -5.46M |
| Net Income | -15.95M | -9.14M | -5.1M |
| Year End January 30 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 6.88M | 4.39M | 543k |
| Total Liabilities | 3.85M | 4.44M | 2.07M |
| Total Equity | 3.02M | -49k | -1.53M |
| Year End January 30 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Operating | -8.59M | -7.36M | -2.38M |
| Investing | -1.69M | -95k | -20k |
| Financing | 11.5M | 6.4M | 2.46M |
| Market Cap | 3.09M |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 3.02 |
| Price to Cash Ratio | 7.77 |
| Price to Book Ratio | -2.07 |
| Dividend Yield | - |
| Shares Outstanding | 39.52M |
| Average Volume (1 week) | 1.42k |
| Average Volume (1 Month) | 6.17k |
| 52 Week Change | -44.14% |
| 52 Week High | 0.26 |
| 52 Week Low | 0.0422 |
| Spread (Intraday) | 0.04 (43.6%) |
| Company Name | Awakn Life Sciences Corporation (QB) |
| Address |
301-217 queen street w toronto, ontario M5V 0R2 |
| Website | https://awaknlifesciences.com/ |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
